Oklo shares climbed 4.2% in pre-open trading after the company disclosed that its Groves Isotope Test Reactor, located in Lockhart, Texas, achieved first criticality on August 6, 2026. First criticality denotes the point at which a reactor sustains a controlled, self-sustaining nuclear chain reaction at low power, and Oklo said the Groves facility reached that threshold.
The announcement represents a major operational milestone for the developer. It converts Oklo from a pre-revenue entity into a firm that has physically demonstrated nuclear fission at a commercial, privately owned site. The company also emphasized the project’s status as the first under the U.S. Department of Energy's Reactor Pilot Program to reach criticality on a greenfield site built on private land, with fuel, equipment and systems supplied entirely by the private sector.
Oklo reached the first criticality milestone in under a year from groundbreaking, a pace that analysts had previously identified as a key proof point for execution credibility. Investors reacted in the pre-market, positioning around the development ahead of the company’s upcoming quarterly disclosure.
Oklo is scheduled to release its Q2 2026 financial results before the market opens on August 7. Street estimates heading into the report show a modeled loss of approximately $0.16 per share, and the criticality news has shifted investor sentiment ahead of that release.
The broader market offered little support for Oklo’s move. The S&P 500 was modestly positive at +0.1% while the Nasdaq was slightly lower at -0.5% in pre-market trading, indicating the strength in OKLO was largely company-specific rather than driven by a general market rally.
Other participants in the advanced nuclear space, such as NuScale Power and X-Energy, have been pursuing related regulatory and operational milestones. Still, the Groves reactor reaching first criticality gives Oklo a distinct first-mover achievement within the DOE Reactor Pilot Program framework.
Taken together, the Groves announcement appears to be the primary catalyst for the pre-open share movement, validating years of development efforts and regulatory navigation. With a now-operational test reactor supporting its isotope business ambitions and quarterly results imminent, investor positioning around Oklo moved meaningfully higher heading into the market open.
Market context and immediate outlook
- Oklo announced first criticality for the Groves Isotope Test Reactor on August 6, 2026.
- The reactor is on private land in Lockhart, Texas, and is the first Reactor Pilot Program project to reach criticality on a greenfield private site with private-sector supplied fuel and systems.
- Oklo will report Q2 2026 results before the market opens on August 7, with consensus modeling a loss of about $0.16 per share.